Coates, E. E., Edupuganti, S., Chen, G. L., Happe, M., Strom, L., Widge, A., Florez, M. B., Cox, J. H., Gordon, I., Plummer, S., Ola, A., Yamshchikov, G., Andrews, C., Curate-Ingram, S., Morgan, P., Nagar, S., Collins, M. H., Bray, A., Nguyen, T., Stein, J., Case, C. L., Kaltovich, F., Wycuff, D., Liang, C. J., Carlton, K., Vazquez, S., Mascola, J. R., Ledgerwood, J. E., , , Butler, E., Winter, J., Xu, J., Sherman, A., Kelley, C., Fredrick, R., Rouphael, N., Phadke, V., Whitney, C., Alvarez, A., Dennis, R., Fineman, R., Lankford-Turner, P., Yi, S., Lai, L., Burch, G., Gupta, S., Berkowitz, N., Carter, C., Beck, A., Larkin, B., Taylor, S., Alger, M., Bahorich, J., Lynch Chamberlain, A., Chang, Y., Chaudhuri, R., Cooper, J., Demirji, J., Yang, F., Fernald, A., Gollapudi, D., Holland-Linn, J., Kueltzo, L., Lee, J., Liu, J., Liu, X., Mowery, R., O'Connell, S., Rosales-Zavala, E., Sands, J., Wang, X., Weng, S., & Witter, S. (2022). safety and immunogenicity of a trivalent virus-like particle vaccine against western, eastern, and Venezuelan equine encephalitis viruses: a phase 1, open-label, dose-escalation, randomised clinical trial. Lancet infectious diseases, 22(8), 1210–1220. http://access.bl.uk/ark:/81055/vdc_100159752893.0x000018